Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Human immunodeficiency virus (HIV) II infection category B1
0.070 Biomarker disease BEFREE Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles. 25038404 2014
Human immunodeficiency virus (HIV) II infection category B1
0.070 AlteredExpression disease BEFREE Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus. 24503066 2014
Human immunodeficiency virus (HIV) II infection category B1
0.070 Biomarker disease BEFREE The best characterized members of this family are APOBEC3G (A3G) and APOBEC3F (A3F) and their restriction of HIV. 23555255 2013
Human immunodeficiency virus (HIV) II infection category B1
0.070 Biomarker disease BEFREE Here, we report a detailed examination of human APOBEC3 gene expression, focusing on APOBEC3G (A3G) and APOBEC3F (A3F), which are potent inhibitors of human immunodeficiency virus type 1 (HIV-1) infection but are suppressed by HIV-1 Vif. 19587057 2009
Human immunodeficiency virus (HIV) II infection category B1
0.070 Biomarker disease BEFREE APOBEC3G and APOBEC3F restrict human immunodeficiency virus type 1 (HIV-1) replication in vitro through the induction of G-->A hypermutation; however, the relevance of this host antiviral strategy to clinical HIV-1 is currently not known. 16940537 2006
Human immunodeficiency virus (HIV) II infection category B1
0.070 Biomarker disease BEFREE The cytoplasmic single-stranded DNA cytidine deaminases APOBEC3G and APOBEC3F block HIV replication by introducing premature stop codons into the viral genome. 16842218 2006
Human immunodeficiency virus (HIV) II infection category B1
0.070 AlteredExpression disease BEFREE APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count. 16439564 2006